Search

Search Constraints

You searched for: Author/Creator Zeuzem, Stefan

Search Results

1. 821Daclatasvir and Asunaprevir Plus Peginterferon Alfa-2a and Ribavirin in Patients With HCV Genotype 1 or 4 Infection: Phase 3 HALLMARK-QUAD Results. (December 2014)

2. A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care123456789. Issue 4 (8th April 2013)

3. A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation. (28th January 2016)

4. A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment. Issue 2 (7th June 2020)

5. A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction. Issue 2 (12th December 2020)

6. Absence of HBV Reactivation in Patients With Resolved HBV Infection Following DAA Therapy for Hepatitis C: A 1-Year Follow-up Study. (15th December 2018)

8. Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?. Issue 5 (17th June 2021)